Chen Bing, Vogan Erik M, Gong Haiyun, Skehel John J, Wiley Don C, Harrison Stephen C
Children's Hospital Laboratory of Molecular Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA.
Nature. 2005 Feb 24;433(7028):834-41. doi: 10.1038/nature03327.
Envelope glycoproteins of human and simian immunodeficiency virus (HIV and SIV) undergo a series of conformational changes when they interact with receptor (CD4) and co-receptor on the surface of a potential host cell, leading ultimately to fusion of viral and cellular membranes. Structures of fragments of gp120 and gp41 from the envelope protein are known, in conformations corresponding to their post-attachment and postfusion states, respectively. We report the crystal structure, at 4 A resolution, of a fully glycosylated SIV gp120 core, in a conformation representing its prefusion state, before interaction with CD4. Parts of the protein have a markedly different organization than they do in the CD4-bound state. Comparison of the unliganded and CD4-bound structures leads to a model for events that accompany receptor engagement of an envelope glycoprotein trimer. The two conformations of gp120 also present distinct antigenic surfaces. We identify the binding site for a compound that inhibits viral entry.
人类和猿猴免疫缺陷病毒(HIV和SIV)的包膜糖蛋白在与潜在宿主细胞表面的受体(CD4)和共受体相互作用时会经历一系列构象变化,最终导致病毒膜与细胞膜融合。已知包膜蛋白中gp120和gp41片段的结构,分别对应于它们附着后和融合后的构象。我们报告了一个完全糖基化的SIV gp120核心的晶体结构,分辨率为4埃,其构象代表了它在与CD4相互作用之前的预融合状态。该蛋白的部分结构与CD4结合状态下的结构有明显不同。未结合配体和结合CD4的结构比较,得出了一个关于包膜糖蛋白三聚体受体结合时伴随事件的模型。gp120的两种构象也呈现出不同的抗原表面。我们确定了一种抑制病毒进入的化合物的结合位点。